Evidence map›Paper›PMID 37588090›Full record

ArticleFrontiers in oncology2023

Association study between

Jian Song, Kaixuan Wang, Zhaowei Chen, Dunjing Zhong, Li Li, Liangliang Guo, Shuyong Yu

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Jian SongDepartment of Gastroenterology, Southern University of Science and Technology Hospital, Shenzhen, Guangdong, China.
Kaixuan WangDepartment of Gastroenterology, The First Affiliated Hospital of Naval Medical University, Shanghai, China.
Zhaowei ChenDepartment of Gastroenterology, Hainan Cancer Hospital, Haikou, Hainan, China.
Dunjing ZhongDepartment of Gastroenterology, Hainan Cancer Hospital, Haikou, Hainan, China.
Li LiDepartment of Gastrointestinal Surgery, Hainan Cancer Hospital, Haikou, Hainan, China.
Liangliang GuoDepartment of Gastroenterology, Hainan Cancer Hospital, Haikou, Hainan, China.
Shuyong YuDepartment of Gastrointestinal Surgery, Hainan Cancer Hospital, Haikou, Hainan, China.
Hainan Medical College Hospital · CNSouthern University of Science and Technology · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Colorectal cancer (CRC) is the third most common malignant tumor in the world. The morbidity and mortality rates in Western countries have decreased, but they are still on the rise in China. Methods: A total of 1,339 subjects were randomly enrolled in our study. After extracting their DNA, three single-nucleotide polymorphisms (SNPs) of Results: Conclusion: This study is the first to report between

Indexed as

C10orf90clinical featurescolorectal cancerdemographic characteristicsgene polymorphisms

Identifiers

PMID37588090
PMCPMC10425599
OpenAlexW4385410933

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.